STHLM3 - Prostate Cancer Diagnostic Trial
STHLM3 - Prostate Cancer Diagnostic Trial
STHLM3 is a paired diagnostic trial aiming to assess whether a panel of biomarkers for prostate cancer can substantially reduce the proportion of men referred to biopsy whilst maintaining sensitivity for aggressive prostate cancer
Inclusion Criteria:
Exclusion Criteria: